Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

朱本元 (Pen-Yuan Chu)

[簡介]

  • 學歷
    • 國防醫學院 醫學系 醫學士
  • 經歷
    現職:
    • - 迄今 臺北榮總耳鼻喉頭頸醫學部 喉頭頸科 主治醫師
    • - 迄今 台北榮總頭頸癌治療團隊 召集人
    • - 迄今 教育部 部定教授
    • - 迄今 台灣耳鼻喉科醫學會 副理事長 醫院醫療組召集人
    • - 迄今 台灣音聲醫學研究會 常務理事
    • - 迄今 中華民國無喉者復聲協會 理事長
    • - 迄今 亞洲無喉者聯盟(AFLA) 副理事長
    經歷:
    • - 臺北榮總耳鼻喉頭頸醫學部 部主任 (2018/08-2024/07)
    • - 台灣頭頸部腫瘤醫學會 理事長 (2021/07-2024/06)
    • - 美國紐約Memorial Sloan-Kettering Cancer Center 研究員 (2001/01-2001/12)
    • - 德國 University of Goettingen 短期進修 (2006/11)
  • 醫療專長
    1. 頭頸癌(口腔癌、口咽癌、喉癌、下咽癌)的診斷與治療
    2. 頭頸癌之器官保留治療
    3. 頭頸部腫瘤微創手術(二氧化碳雷射顯微手術)
    4. 甲狀腺腫瘤、唾液腺腫瘤及頸部腫塊的診斷與治療
    5. 嗓音異常的診斷與治療

[著作]

(*Corresponding author)

  1. Lee TL, Chen TH, Kuo YJ, Lan HY, Yang MH*, Chu PY*. Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma. Neoplasia. 2023 Jan;35:100855. doi: 10.1016/j.neo.2022.100855. Epub 2022 Nov 19. (2021 IF=6.218, Ranking=66/245 in ONCOLOGY)
  2. Liu CH, Chien PJ, Hung LT, Wang LM, Kao YC, Tsai YJ, Chu PY*. Long-term Oncologic Results and Voice Outcomes in Patients With Glottic Cancer After Modified Type III Cordectomy. Otolaryngol Head Neck Surg. 2022 Nov;167(5):839-845. (2021 IF=5.591, Ranking=3/43 in OTORHINOLARYNGOLOGY)
  3. Cheng HY, Hsieh CH, Lin PH, Chen YT, Hsu DS, Tai SK, Chu PY, Yang MH*. Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J Immunother Cancer. 2022 Aug;10(8):e004832. (2021 IF=12.485, Ranking=25/245 in ONCOLOGY)
  4. Lai CL, Chen TH, Chang PM, Tai SK, Chu PY, Yang MH*. Efficacy of cetuximab-containing regimens in the treatment of recurrent/metastatic head and neck cancer after progression to immune checkpoint inhibitors. J Chin Med Assoc. 2022 Jun 1;85(6):687-692. (2021 IF=3.396, Ranking=71/172 in MEDICINE, GENERAL & INTERNAL)
  5. Liao CT, Wen YW, Lee SR, Ng SH, Liu TW, Tsai ST, Tsai MH, Lin JC, Chien CY, Lou PJ, Wang CP, Chu PY, Leu YS, Tsai KY, Terng SD, Chen TM, Wang CH, Chen WC, Lee LY, Lin CY, Wang HM, Fang TJ, Huang SF, Kang CJ, Chang KP, Yen TC, Yang LY*, Lin CH*; Taiwan Oral Cavity Cancer Advisory Group. Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps. Ann Surg Oncol. 2022 Feb;29(2):1130-1140. (2021 IF=4.339, Ranking=37/213 in SURGERY)
  6. Ting KC, Lee TL, Li WY, Chang CF, Chu PY, Wang YF, Tai SK*. Perineural invasion/lymphovascular invasion double positive predicts distant metastasis and poor survival in T3-4 oral squamous cell carcinoma. Sci Rep. 2021 Oct 5;11(1):19770. (2021 IF=4.997, Ranking=19/74 in MULTIDISCIPLINARY SCIENCES)
  7. Huang YW, Wang YP, Lee TL, Chang CF, Hou MC, Tai SK, Chu PY*. Image-enhanced endoscopy for detection of second primary esophageal neoplasms in patients with hypopharyngeal cancer: Prevalence, risk factors, and characteristics. J Chin Med Assoc. 2021 Oct 1;84(10):963-968. (2021 IF=3.396, Ranking=71/172 in MEDICINE, GENERAL & INTERNAL)
  8. Lin MC, Leu YS, Chiang CJ, Ko JY, Wang CP, Yang TL, Chen TC, Chen CN, Chen HL, Liao CT, Tsai ST, Lin JC, Chu PY, Tsai KY, Tsai MH, Huang HC, Yang MH, Wu YH, Terng SD, Chien CY, Liu TW, Lee WC, Lou PJ*. Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis. Oral Oncol. 2021 Aug;119:105358. (2021 IF=5.972, Ranking=6/92 in DENTISTRY, ORAL SURGERY & MEDICINE)
  9. Chien PJ, Hung LT, Wang LW, Yang MH, Chu PY*. Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery. Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2983-2992. (2021 IF=3.236, Ranking=12/43 in OTORHINOLARYNGOLOGY)
  10. Chang H, Chu PY*. Extramedullary plasmacytoma of hypopharynx treated using transoral laser microsurgery and adjuvant radiotherapy. J Chin Med Assoc. 2020 Aug;83(8):791-793. (2021 IF=3.396, Ranking=71/172 in MEDICINE, GENERAL & INTERNAL) CASE REPORT
  11. Lee TL, Chiu PH, Li WY, Yang MH, Wei PY, Chu PY, Wang YF, Tai SK*  Nerve-tumour interaction enhances the aggressiveness of oral squamous cell carcinoma. Clin Otolaryngol. 2019 Nov;44(6):1087-1095. (2021 IF=2.729, Ranking=19/43 in OTORHINOLARYNGOLOGY)
  12. Lee SC*, Wang TJ*, Chu PY*. Predictors of weight loss during and after radiotherapy in patients with head and neck cancer: A longitudinal study. Eur J Oncol Nurs. 2019 Apr;39:98-104. (2021 IF=2.588, Ranking=32/123 in NURSING)
  13. Cheng YJ, Tsai MH, Chiang CJ, Tsai ST, Liu TW, Lou PJ, Liao CT, Lin JC, Chang JT, Tsai MH, Chu PY, Leu YS, Tsai KY, Terng SD, Chien CY, Yang MH, Hao SP, Wang CC, Tsai MH, Chen HHW, Kuo C, Wu YH*. Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis. Cancer Med. 2018 Jun 14;7(7):3073-83. (2021 IF=4.711, Ranking=106/245 in ONCOLOGY)
  14. Hsu CC, Li WY, Chu PY*. Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review. Medicine (Baltimore). 2018 Mar;97(11):e0095. CASE REPORT
  15. Chen SC, Chang PM, Wang HJ, Tai SK, Chu PY*, Yang MH*. PD-L1 expression is associated with p16INK4A expression in non-oropharyngeal head and neck squamous cell carcinoma. Oncol Lett. 2018 Feb;15(2):2259-2265. (2021 IF=3.111, Ranking=176/245 in ONCOLOGY)
  16. Hung LT, Huang HI, Wang LW, Yang MH, Chu PY*. Oncologic results and quality of life in patients with squamous cell carcinoma of hypopharynx after transoral laser microsurgery. Lasers Surg Med. 2018 Feb;50(2):117-124. (2021 IF=2.703, Ranking=95/213 in SURGERY)
回到最上